Articles

Why Your Biotech Company is Still Cyber-Vulnerable

The dangers facing biotech Does your enterprise handle any biotech or pharmaceutical-adjacent field, product, or service? Guess what, you’re likelier than ever to suffer a cyber attack or major breach event. Biotech is a branching field, rooted in critical infrastructure and public safety (medicine, vaccines, healthcare). During the COVID pandemic, the need to both develop …

Why Your Biotech Company is Still Cyber-Vulnerable Read More »

Modern networks lack long-term cybersecurity solutions and architecture

There’s no real long-term goal for current security models When you consider current cybersecurity plans, you imagine it in the short term. Proactive architecture for immediate threats with roadmap considerations for, say, the next handful of years. But what about in the next five years? What about in the next decade? A lack of long-term …

Modern networks lack long-term cybersecurity solutions and architecture Read More »

The “mainstream” crypto market is still rife with scams and danger

Danger of scam-related crypto markets Several months previous I did a shotgun article discussing the scam-ridden antics of NFTs and general cryptocurrency. For one, crypto is threat-adjacent to ransomware and the go-to for demanded payments. As for NFTs, ever since their inception, they’ve been swarmed by scams and outright ponzi schemes. Collections of stolen digital …

The “mainstream” crypto market is still rife with scams and danger Read More »